Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $295 | $178 | $201 | $310 |
| - Cash | $18 | $13 | $15 | $21 |
| + Debt | $60 | $31 | $36 | $11 |
| Enterprise Value | $338 | $196 | $222 | $300 |
| Revenue | $76 | $55 | $60 | $73 |
| % Growth | 36.9% | -7.4% | -18.1% | – |
| Gross Profit | $34 | $30 | $33 | $50 |
| % Margin | 45.7% | 53.9% | 55.8% | 68% |
| EBITDA | -$40 | -$31 | -$35 | -$8 |
| % Margin | -53.5% | -55.7% | -58.9% | -10.7% |
| Net Income | -$55 | -$40 | -$43 | -$14 |
| % Margin | -72.9% | -72.9% | -72.3% | -18.9% |
| EPS Diluted | -0.008 | -0.011 | -0.038 | -0.012 |
| % Growth | 21.5% | 71.5% | -213.3% | – |
| Operating Cash Flow | -$39 | -$32 | -$29 | -$14 |
| Capital Expenditures | -$4 | -$3 | -$5 | -$3 |
| Free Cash Flow | -$44 | -$36 | -$34 | -$18 |